Acrux Limited

Capital Gains Tax exemptions remain in place for Acrux

Acrux raises $1.6 million via Share Placement

Australian company unlocks a new era for women's health globally with an innovative delivery system for Female testosterone in women with low libido

Acrux strategy focuses on Female Testosterone for low libido

Acrux receives $0.55m advance on FY26 R&D Tax Incentive